Form 8-K NovoCure Ltd For: Jan 05

Go back to Form 8-K NovoCure Ltd For: Jan 05

Novocure (NVCR) Climbs 70% After Pivotal LUNAR Study in NSCLC Met Primary Overall Survival Endpoint

January 5, 2023 7:10 AM EST

Novocure (NASDAQ: NVCR) Climbs 70% After Pivotal LUNAR Study in NSCLC Met Primary Overall Survival Endpoint

... More